Alzheimer’s Association Welcomes Continued Progress in Alzheimer’s Treatment with FDA Approval of Leqembi Subcutaneous Starter Dose

Alzheimer’s Association and Alzheimer’s Impact Movement Statement on OMB’s Proposed Rule on Federal Financial Assistance

Recognizing AIM’s July Advocate of the Month: Dalma Riquelme